Hsu Chao-Wen, Lin Chieh-Hsin, Wang Jui-Ho, Wang Hsin-Tai, Ou Wen-Chieh, King Tai-Ming
Division of Colorectal Surgery, Department of Surgery, Kaohsiung Veteran General Hospital, 386 Ta-Chung 1st RD., Kaohsiung, 81346, Taiwan, ROC.
World J Surg. 2009 Feb;33(2):333-9. doi: 10.1007/s00268-008-9850-z.
The number of lymph nodes required for accurate staging is a critical component in early-stage (stage A and B) colorectal cancer (CRC). Current guidelines demand at least 12 lymph nodes to be retrieved. Results of previous studies were contradictory in factors, which influenced the number of harvested lymph nodes. This study was designed to determine the factors that influence the number of harvested lymph nodes (> or =12) in early-stage CRC in a single institution.
Between 2003 and 2007, data on patients who underwent surgery for early-stage CRC were analyzed retrospectively. Data for a total of 470 patients were collected and all the tumor-bearing specimens were fixed with node identification performed. Several possible factors that influence 12 or more harvested lymph nodes were investigated and classified into four aspects: (1) operating surgeon, (2) examining pathologist, (3) patient (age, sex, and body mass index), and (4) disease (maximal length of tumor, length of specimen, tumor localization, tumor cell differentiation, Dukes stage, type of resection, and type of tumor).
A total of 289 patients (61.5%) with 12 or more harvested lymph nodes and 181 patients (38.5%) with < 12 lymph nodes were analyzed. The results demonstrate that within a single institution the maximal length of tumor, tumor localization, and depth of tumor invasion according to Dukes stage were independent influencing factors of 12 or more harvested lymph nodes. Maximal length of tumor was associated with more harvested lymph nodes (P < 0.001). Neither the operating surgeon nor the examining pathologist had significant influence on the number of harvested lymph nodes.
The number of harvested lymph nodes was highly variable in patients who underwent resection of early-stage CRC. Neither the operating surgeon nor the examining pathologist had significant influence on the number of harvested lymph nodes. Therefore, from the viewpoint of the surgeons, disease itself is the most important factor influencing the number of harvested lymph nodes.
准确分期所需的淋巴结数量是早期(A 期和 B 期)结直肠癌(CRC)的一个关键组成部分。当前指南要求至少切除 12 枚淋巴结。以往研究的结果在影响切除淋巴结数量的因素方面相互矛盾。本研究旨在确定在单一机构中影响早期 CRC 患者切除淋巴结数量(≥12 枚)的因素。
回顾性分析 2003 年至 2007 年间接受早期 CRC 手术患者的数据。共收集了 470 例患者的数据,并对所有带有肿瘤的标本进行固定并进行淋巴结识别。研究了几个可能影响切除 12 枚或更多淋巴结的因素,并将其分为四个方面:(1)主刀医生,(2)病理检查医生,(3)患者(年龄、性别和体重指数),以及(4)疾病(肿瘤最大长度、标本长度、肿瘤定位、肿瘤细胞分化、Dukes 分期、切除类型和肿瘤类型)。
共分析了 289 例(61.5%)切除 12 枚或更多淋巴结的患者和 181 例(38.5%)切除淋巴结少于 12 枚的患者。结果表明,在单一机构中,肿瘤最大长度、肿瘤定位以及根据 Dukes 分期的肿瘤浸润深度是切除 12 枚或更多淋巴结的独立影响因素。肿瘤最大长度与切除更多淋巴结相关(P < 0.001)。主刀医生和病理检查医生对切除淋巴结的数量均无显著影响。
接受早期 CRC 切除术的患者切除淋巴结的数量差异很大。主刀医生和病理检查医生对切除淋巴结的数量均无显著影响。因此,从外科医生的角度来看,疾病本身是影响切除淋巴结数量的最重要因素。